Monte Rosa Therapeutics AG

City:

Basel

Country:

Switzerland

Published Applications:

Last publication date:

2025-07-31

Patent Grants:

Last grant date:

2025-11-04

Top Inventors for applications by Monte Rosa Therapeutics AG

These are the the leading inventors for applications assigned to Monte Rosa Therapeutics AG:

Bernhard Fasching 3 Basel, Switzerland
Andreas Ritzén 2 Basel, Switzerland
Laura Ann McAllister 2 Basel, Switzerland
Elisa Liardo 2 Basel, Switzerland

Freya Harvey 1 Basel, Switzerland
Thomas Ryckmans 1 Basel, Switzerland
Vladimiras Oleinikovas 1 Basel, Switzerland
Mathieu Lesieur 1 Basel-Stadt, Switzerland

Lorenzo Delarue Bizzini 1 Basel-Stadt, Switzerland
Laura McAllister 1 Basel, Switzerland
Xavier Lucas Cabré 1 Basel, Switzerland
Alexander Flohr 1 Basel, Switzerland

Vladas Oleinikovas 1 Basel, Switzerland

Recent patent applications by Monte Rosa Therapeutics AG

Monte Rosa Therapeutics AG based in Basel, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-07-31 ✅ Patent 12,459,920 granted on 2025-11-04

US20250243180A1

Chemistry; metallurgy

TARGETED PROTEIN DEGRADATION

#2 | 2024-08-29 ✅ Patent 12,257,247 granted on 2025-03-25

US20240285604A1

Human necessities

Targeted degradation of VAV1

#3 | 2024-03-14 ✅ Patent 12,391,663 granted on 2025-08-19

US20240083869A1

Chemistry; metallurgy

ISOINDOLINONE COMPOUNDS

Also check out Monte Rosa Therapeutics AG's (Basel, Switzerland) applicant profile with 5 patent applications submitted.

AssigneeID:

639312 ⎘